Cargando…
Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study
BACKGROUND: Patients undergoing liver transplantation with preexisting renal dysfunction are prone to further renal impairment with the early postoperative use of Calcineurin-inhibitors. However, there is only little scientific evidence for the safety and efficacy of de novo CNI free "bottom-up...
Autores principales: | Schnitzbauer, Andreas A, Scherer, Marcus N, Rochon, Justine, Sothmann, Johannes, Farkas, Stefan A, Loss, Martin, Geissler, Edward K, Obed, Aiman, Schlitt, Hans J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945344/ https://www.ncbi.nlm.nih.gov/pubmed/20840760 http://dx.doi.org/10.1186/1471-2369-11-24 |
Ejemplares similares
-
A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT
por: Goralczyk, Armin D, et al.
Publicado: (2010) -
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
por: Geissler, Edward K
Publicado: (2015) -
Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
por: Obed, Aiman, et al.
Publicado: (2007) -
mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma
por: Scheller, T, et al.
Publicado: (2015) -
Cancer and mTOR inhibitors in kidney transplantation recipients
por: Kao, Chih-Chin, et al.
Publicado: (2018)